Edding Genor Group (6998 HK)

Edding Genor Group is an integrated specialty biopharmaceutical company focused on oncology, autoimmune diseases, cardiovascular diseases, respiratory diseases, and anti-infectives. It discovers, develops, manufactures, and commercializes biopharmaceutical products, primarily through acquiring branded drug assets and licensing patented drugs. The company is headquartered in Shanghai, China, and was founded in 2001.